The board of directors of Uni-Bio Science Group Limited announced that with effect from April 1, 2014: Mr. Lou Iok Kuong resigned as an independent non-executive Director, the chairman of the remuneration committee of the Board (Remuneration Committee) and a member of each of the audit committee (Audit Committee) and the nomination committee (Nomination Committee) of the Board due to his other career commitments which require more of his time; and Mr. Ng Pak Kin, Danny (Mr. Ng) resigned as an independent non-executive Director and a member of each of the Audit Committee and the Remuneration Committee due to his other career commitments which require more of his time. Each of Mr. Lou and Mr. Ng has confirmed that he has no disagreement with the Company and the Board, and there are no other matters relating to his resignation that need to be brought to the attention of the shareholders of the Company. The Board announced that with effect from April 1, 2014, each of Dr. Carl Aslan Jason Morton Firth (Dr. Firth) and Mr. Zhao Zhi Gang (Mr. Zhao) has been appointed as an independent non-executive Director.

Dr. Firth, aged 41, is the chief executive officer and founder of ASLAN Pharmaceuticals Pte Ltd. Dr. Firth was previously the Head of Asia Healthcare at Bank of America Merrill Lynch. Mr. Zhao has over 20 year-experience in corporate finance and audit practice with various publicly listed companies and PricewaterhouseCoopers in the U.S. and in China. Mr. Zhao is currently the chief financial officer (CFO) in Borqs Beijing Limited and an independent director of Zuoan Fashion Ltd. The Board announced that with effect from 1 April 2014, following the resignation of Mr. Lou and Mr. Ng, Dr. Firth has been appointed as the chairman of the Remuneration Committee and a member of each of the Audit Committee and the Nomination Committee and Mr. Zhao has been appointed as a member of each of the Audit Committee, the Remuneration Committee and the Nomination Committee.